Skip to main content

Table 2 Clinical features indicating active SJIA requiring initiation or increase of corticosteroids

From: Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology

 

On Line

Questionnaire

Face-to-Face Conference

Consensus reached (%)

Increase cortico-steroids?

Consensus not reached

Consensus*

Increase corticosteroids in the presence of

    

Symptomatic pericarditis

Yes

Yes

 

Endorsed

Symptomatic myocarditis

Yes

Yes

 

Endorsed

Asymptomatic myocarditis (imaging only)

Yes

Yes

 

Endorsed

Symptomatic pleural effusion

Yes

Yes

 

Endorsed

Symptomatic pneumonitis

Yes

Yes

 

Endorsed

Fever for 6 of last 10 days

Yes

Yes

 

Changed to “No”

Fever for 8 of last 14 days

Yes

Yes

 

Changed to “No”

Anemia, Hgb <7 g/dl

Yes

Yes

 

Refined as “No” if ≥ 6.5 and asymptomatic

Anemia, Hgb 7–9 g/dl

  

X

No if ≥ 6.5 g/dl and symptomatic

SJIA rash alone

Yes

No

 

Endorsed

Anorexia alone

Yes

No

 

Endorsed

Low albumin alone

Yes

No

 

Endorsed

Severe fatigue alone

  

X

No

Weight loss alone

  

X

No

Worsening synovitis*

Not evaluated

  

No

  1. *Items from on-line questionnaire reaching consensus were reviewed and either endorsed or changed based on discussion during face-to-face consensus process.